On Tuesday, KeyBanc analysts raised the price target for Rocket Lab USA (NASDAQ:RKLB) stock to $29 from $28, while maintaining an Overweight rating. The decision reflects growing confidence in the ...

On Tuesday, Canaccord Genuity analysts lowered the price target for Rocket Pharmaceuticals stock (NASDAQ:RCKT) to $11 from $34 while maintaining a Buy rating. Currently trading at $2.77, the stock has ...

The deal is so good that Amazon is rapidly clearing out its stock, so you need to make sure you get it before it runs out of stock. See at Amazon The Ugreen 65W USB-C (and USB-A) charger is a real ...

Rocket Companies (NYSE:RKT – Get Free Report) had its target price upped ... The firm presently has a “neutral” rating on the stock. UBS Group’s target price points to a potential upside ...

Shares of Rocket Cos. Inc. RKT slipped 2.45% to $12.75 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.13 ...

The decision by Evercore ISI follows a recent unfortunate event in Rocket Pharmaceuticals’ clinical program. According to InvestingPro data, the stock has declined over 58% in the past week alone, ...

In her free time, she enjoys binging podcasts, scouring thrift stores for unique home décor and spoiling the heck out of her dogs. Stock market drops can be scary, especially when your retirement ...

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its target price ... a “buy” rating on the biotechnology company’s stock. Bank of America‘s price target points to a potential ...

On Thursday, JMP Securities maintained a Market Perform rating on Rocket Lab USA (NASDAQ:RKLB) stock following the company’s announcement of its intent to purchase Geost LLC. The deal, valued at $275 ...